Evidence
DNA Repair (Amst). 2024 Apr 11;139:103678. doi: 10.1016/j.dnarep.2024.103678. Online ahead of print.
ABSTRACT
Alzheimer disease (AD) is the most prominent form of dementia and has received considerable attention due to its growing burden on economic, healthcare and basic societal infrastructures. The two major neuropathological hallmarks of AD, i.e., extracellular amyloid beta (Aβ) peptide plaques and intracellular hyperphosphorylated Tau neurofibrillary tangles, have been the focus of much research, with an eye on understanding underlying disease mechanisms and identifying novel therapeutic avenues. One often overlooked aspect of AD is how Aβ and Tau may, through indirect and direct mechanisms, affect genome integrity. Herein, we review evidence that Aβ and Tau abnormalities induce excessive genomic stress and impair genome maintenance mechanisms, events that can promote DNA damage-induced neuronal cell loss and associated brain atrophy.
PMID:38669748 | DOI:10.1016/j.dnarep.2024.103678
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Genomic stress and impaired DNA repair in Alzheimer disease
🌐 90 Days
VR Related Evidence Matrix
- Microglial inflammation in genome instability: A neurodegenerative perspective
- Corrigendum to
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Is Alzheimer disease a disease?
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Nanopore-based DNA long-read sequencing analysis of the aged human brain
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates
- Alzheimer's Disease: The Past, Present, and Future of a Globally Progressive Disease
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone
- Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years
- Local structural preferences in shaping tau amyloid polymorphism
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- Tau accumulation and its spatial progression across the Alzheimer's disease spectrum
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathology
- Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems
- Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment
- Using Drosophila amyloid toxicity models to study Alzheimer's disease
- Alterations of Structural Network Efficiency in Early-Onset and Late-Onset Alzheimer's Disease
- Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer's astrocytes
- Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
- The Biochemistry Behind Cognitive Decline: Biomarkers of Alzheimer's Disease
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease
- Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
- Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
- What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries
- RNA therapeutics for neurological disease
- Innate immune activation in neurodegenerative diseases
- Memory Circuits in Dementia: The Engram, Hippocampal Neurogenesis and Alzheimer's disease
- Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
- Present and future of Blood-Based biomarkers of Alzheimer's Disease: Beyond the classics
- Precision proteoform design for 4R tau isoform selective templated aggregation
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- Effects of APOE e4 and Neuropathological Diagnoses on Neuropsychiatric Symptoms: Mediation Analyses and Likely Causation in an Integrated NACC Database
- Mitochondrial DNA Disorders: the (long and winding) road to treatment
- β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer's disease
- Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders
- mRNA-responsive two-in-one nanodrug for enhanced anti-tumor chemo-gene therapy
- Genetic Determinants of Vascular Dementia
- Differential DNA methylation in the brain as potential mediator of the association between traffic-related PM2.5 and neuropathology markers of Alzheimer's disease
- Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases
- Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias
- Mechanisms of sex differences in Alzheimer's disease
- Pathogenic soluble tau peptide disrupts endothelial calcium signaling and vasodilation in the brain microvasculature
Evidence Blueprint
Genomic stress and impaired DNA repair in Alzheimer disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Genomic stress and impaired DNA repair in Alzheimer disease
🌐 365 Days
VR Related Evidence Matrix
- Microglial inflammation in genome instability: A neurodegenerative perspective
- Corrigendum to
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Tau and Alzheimer's disease: Past, present and future
- Is Alzheimer disease a disease?
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease
- Deregulation of the Glymphatic System in Alzheimer's Disease: Genetic and Non-Genetic Factors
- GLP-1/Sigma/RAGE Receptors: An evolving picture of Alzheimer's Disease pathology and treatment
- Neuropathology of Alzheimer's Disease
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- The role of PIMT in Alzheimer's disease pathogenesis: A novel hypothesis
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
- Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability
- Alzheimer's Type Neuropathological Changes in a Patient with Depression and Anxiety: A Case Report and Literature Review of Neuropathological Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease
- Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Nanopore-based DNA long-read sequencing analysis of the aged human brain
- Navigating the Dementia Landscape: Biomarkers and Emerging Therapies
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Discovery of Orally Available and Brain Penetrant AEP Inhibitors
- A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
- Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease
- COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- The Role of RIN3 Gene in Alzheimer's Disease Pathogenesis: a Comprehensive Review
- Effects of heterologous human tau protein expression in yeast models of proteotoxic stress response
- Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease
- Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates
- CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
- Alzheimer's Disease: The Past, Present, and Future of a Globally Progressive Disease
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Treatment of the CRND8 mouse model for cerebral amyloid angiopathy, exhibited increased levels of neuron specific enolase in brain tissue following long-term treatment with a modified C5a receptor agonist, accompanied by improved cognitive function
- Decoding metabolic signatures in Alzheimer's disease: a mitochondrial perspective
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Low-dose brain radiation: lowering hyperphosphorylated-tau without increasing DNA damage or oncogenic activation
- Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease
- Disentangling tau: One protein, many therapeutic approaches
- Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)
- Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients
- Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone
- Minocycline effects on memory and learning impairment in the beta-amyloid-induced Alzheimer's disease model in male rats using behavioral, biochemical, and histological methods
- Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years
- Self-Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
- Radiotherapy in Alzheimer's Disease: A Systematic Review
- CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer's disease
- Local structural preferences in shaping tau amyloid polymorphism
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Evaluation of possible neuroprotective effects of virgin coconut oil on aluminum-induced neurotoxicity in an in vitro Alzheimer's disease model
- 3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer's disease using a smart bioink
- Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status
- The elusive role of herpesviruses in Alzheimer's disease: current evidence and future directions
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice